Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III comparison of two buprenorphine transdermal systems in severe cancer pain
2005-000613-35Phase 3Completed
- Sponsor
- Novosis
- Start
- May 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of buprenorphine in cancer pain (2 arms), sponsored by Novosis. Primary endpoints: Number of responders, Analgesic efficacy and 1 more. Started May 2005; status: completed.
02
Drugs
buprenorphine
03
Conditions
cancer pain
Beyond the preview
Go deeper on 2005-000613-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000613-35.